KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Liabilities and Shareholders Equity: 2010-2025

Historic Liabilities and Shareholders Equity for Emergent BioSolutions (EBS) over the last 16 years, with Sep 2025 value amounting to $1.5 billion.

  • Emergent BioSolutions' Liabilities and Shareholders Equity fell 1.14% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 billion, marking a year-over-year decrease of 13.96%. This contributed to the annual value of $1.4 billion for FY2024, which is 23.78% down from last year.
  • According to the latest figures from Q3 2025, Emergent BioSolutions' Liabilities and Shareholders Equity is $1.5 billion, which was up 3.10% from $1.4 billion recorded in Q2 2025.
  • Emergent BioSolutions' Liabilities and Shareholders Equity's 5-year high stood at $3.2 billion during Q4 2022, with a 5-year trough of $1.4 billion in Q4 2024.
  • For the 3-year period, Emergent BioSolutions' Liabilities and Shareholders Equity averaged around $1.8 billion, with its median value being $1.5 billion (2024).
  • Per our database at Business Quant, Emergent BioSolutions' Liabilities and Shareholders Equity grew by 27.27% in 2021 and then crashed by 42.42% in 2023.
  • Over the past 5 years, Emergent BioSolutions' Liabilities and Shareholders Equity (Quarterly) stood at $3.0 billion in 2021, then grew by 7.05% to $3.2 billion in 2022, then tumbled by 42.42% to $1.8 billion in 2023, then declined by 23.78% to $1.4 billion in 2024, then dropped by 1.14% to $1.5 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $1.5 billion for Q3 2025, versus $1.4 billion for Q2 2025 and $1.4 billion for Q1 2025.